{"id":"W4386784489","doi":"10.1158/1557-3265.aacrahns23-po-009","title":"Abstract PO-009: Phase 3 KEYNOTE-630 study of adjuvant pembrolizumab in high-risk locally advanced cutaneous squamous cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Perineural invasion; Pembrolizumab; Lymph node; Radiation therapy; Cancer; Surgery; Oncology; Pathology; Internal medicine; Immunotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002974803,0.00039379,0.001557855,0.0005813,0.0002122473,0.0000266052,0.0006327167,0.0002926039,0.0004819256],"category_scores_gemma":[0.002290985,0.0003452253,0.0002576221,0.00200343,0.0006954463,0.00009595732,0.0006128792,0.002570497,0.0002672022],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006453602,"about_ca_system_score_gemma":0.001319125,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009084088,"about_ca_topic_score_gemma":0.004965627,"domain_scores_codex":[0.9927524,0.0007111013,0.001875539,0.001295698,0.002007872,0.001357423],"domain_scores_gemma":[0.9932891,0.003794551,0.0003530497,0.001300842,0.0007458478,0.0005165836],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02223855,0.00785532,0.8200741,0.0007136809,0.0001419258,0.006673842,0.001629288,0.0006278135,0.0007553227,0.000006126733,0.004917826,0.1343662],"study_design_scores_gemma":[0.04204543,0.014803,0.9361262,0.0002158376,0.0001170659,0.00001924394,0.003364621,0.0002966348,0.001610696,0.0001353517,0.0009139705,0.0003519436],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9916558,0.002794892,0.000002927054,0.0006415986,0.000651476,0.002589384,0.000157645,0.00009615339,0.001410102],"genre_scores_gemma":[0.9951369,0.002589828,0.00005183412,0.00007588624,0.0005701034,0.0005344998,0.00002454911,0.0001128486,0.0009035671],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1340142,"threshold_uncertainty_score":0.9999,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1278324920362891,"score_gpt":0.4910254474834192,"score_spread":0.36319295544713,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}